FDA updates label for Zytiga plus prednisone in metastatic castration-resistant prostate cancer

Lei Zheng got his PhD in San Antonio; now he returns as cancer center director at Mays

In 1996, Lei Zheng, a graduate of Peking Union Medical College, enrolled in the doctorate program at what was then known as the Cancer Therapy & Research Center in San Antonio.

September 06, 2024

Vol.50 No.33

By Paul Goldberg

NCI Director's Report

As NCI’s appropriations stay flat, Rathmell keeps the FY26 bypass budget steady at just under $11.5B
Rathmell: “We understand that there are real economic constraints facing our country and the world. But our gap just can’t keep widening.”

NCI Director Kimryn Rathmell has released her professional judgment budget proposal, requesting nearly $11.5 billion—the same amount as last year’s proposal prepared by her predecessor, Monica Bertagnolli.

September 06, 2024

Vol.50 No.33

By Jacquelyn Cobb

Clinical Trials & Tribulations

Is gastrectomy indicated?
A study recently published in JAMA suggests lower lifetime gastric cancer risk for CDH1 mutation carriers. Will this lead to changes in management recommendations?

A study recently published in JAMA sheds light on cancer risks associated with carrying germline CDH1 mutations, challenging previous, potentially inflated, lifetime cancer risk estimates.

September 06, 2024

Vol.50 No.33

By Rebecca Sutphen, Sue Friedman and Jon Florin

Cancer History Project Conversation with The Cancer Letter

Lung cancer couldn’t slow down physician and athlete Lawrence Phillips

Something odd turned up in one of Lawrence Phillips’s routine health screenings in 2008.

September 06, 2024

Vol.50 No.33

By Deborah Doroshow and McKenzie Prillaman

Obituary

Jeffrey S. Weber, pioneering immunologist and melanoma expert at NYU, dies at 72

We lost Jeff Weber, an amazing medical oncologist, an impactful clinical scientist, a leading immunotherapist, and one of the prominent global experts in melanoma.

September 06, 2024

By Bernard A. Fox, James J. Mulé and Samir N. Khleif

In the Archives

Huiping Liu discusses mentorship, translational research on the UChicago Cancer Luminaries podcast

Huiping Liu, associate professor of pharmacology and medicine at Northwestern University Feinberg School of Medicine and Robert H. Lurie Comprehensive Cancer Center, appeared on the Cancer Luminaries podcast. This series was launched by the UChicago Medicine Comprehensive Cancer Center to mark its 50th year as an NCI-designated center.

September 06, 2024

Vol.50 No.33

FDA updates label for Zytiga plus prednisone in metastatic castration-resistant prostate cancer

YOU MAY BE INTERESTED IN

Lei Zheng got his PhD in San Antonio; now he returns as cancer center director at Mays

As NCI’s appropriations stay flat, Rathmell keeps the FY26 bypass budget steady at just under $11.5B
Rathmell: “We understand that there are real economic constraints facing our country and the world. But our gap just can’t keep widening.”

Is gastrectomy indicated?
A study recently published in JAMA suggests lower lifetime gastric cancer risk for CDH1 mutation carriers. Will this lead to changes in management recommendations?

Lung cancer couldn’t slow down physician and athlete Lawrence Phillips

Jeffrey S. Weber, pioneering immunologist and melanoma expert at NYU, dies at 72

Huiping Liu discusses mentorship, translational research on the UChicago Cancer Luminaries podcast

Renew today!

Subscriber content

Can you spare 10 minutes to complete a survey?

Login

FDA updates label for Zytiga plus prednisone in metastatic castration-resistant prostate cancer

YOU MAY BE INTERESTED IN

Lei Zheng got his PhD in San Antonio; now he returns as cancer center director at Mays

As NCI’s appropriations stay flat, Rathmell keeps the FY26 bypass budget steady at just under $11.5BRathmell: “We understand that there are real economic constraints facing our country and the world. But our gap just can’t keep widening.”

Is gastrectomy indicated?A study recently published in JAMA suggests lower lifetime gastric cancer risk for CDH1 mutation carriers. Will this lead to changes in management recommendations?

Lung cancer couldn’t slow down physician and athlete Lawrence Phillips

Jeffrey S. Weber, pioneering immunologist and melanoma expert at NYU, dies at 72

Huiping Liu discusses mentorship, translational research on the UChicago Cancer Luminaries podcast

Can you spare 10 minutes to complete a survey?

Login

As NCI’s appropriations stay flat, Rathmell keeps the FY26 bypass budget steady at just under $11.5B
Rathmell: “We understand that there are real economic constraints facing our country and the world. But our gap just can’t keep widening.”

Is gastrectomy indicated?
A study recently published in JAMA suggests lower lifetime gastric cancer risk for CDH1 mutation carriers. Will this lead to changes in management recommendations?